Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte C Widemann

Showing results (41-50 of 203) with videos related to

Pageof 21
Sort By:
The Oncologist|January 17, 2020
A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted TherapiesJulia W Cohen, Srivandana Akshintala, Eli Kane, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2015
Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumorsElizabeth Fox, Brigitte C Widemann, Devang Pastakia, et al.
Neuro-Oncology Advances|December 31, 2025
Malignant peripheral nerve sheath tumors in neurofibromatosis type 1 arise from distinct nodular lesions: A retrospective imaging analysisJohannes Salamon, Brigitte C Widemann, Andrea M Gross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Phase I study of O6-benzylguanine and temozolomide administered daily for 5 days to pediatric patients with solid tumorsKatherine E Warren, Alberta A Aikin, Madeleine Libucha, et al.
Investigational New Drugs|December 15, 2015
Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primatesNirali N Shah, Diane E Cole, Cynthia M Lester-McCully, et al.
Ophthalmology|November 8, 2016
Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for CareRobert A Avery, James A Katowitz, Michael J Fisher, et al.
The Journal of Pediatrics|May 27, 2023
Retrospective Cohort Analysis of the Impact of Puberty on Plexiform Neurofibroma Growth in Patients with Neurofibromatosis Type 1Chelsea Kotch, Eva Dombi, Amish C Shah, et al.
Operative Neurosurgery (Hagerstown, Md.)|January 10, 2022
Robotic Nerve Sheath Tumor Resection With Intraoperative Neuromonitoring: Case Series and Systematic ReviewBrian P Curry, Reinier Alvarez, Brigitte C Widemann, et al.
Pediatric Blood & Cancer|August 1, 2012
A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumorsMeredith K Chuk, Alberta Aikin, Trish Whitcomb, et al.
Orphanet Journal of Rare Diseases|October 6, 2012
Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1Rosa Nguyen, Eva Dombi, Brigitte C Widemann, et al.
Pageof 21

Showing results (41-50 of 203) with videos related to

Sort By:
Pageof 21
The Oncologist|January 17, 2020
A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted TherapiesJulia W Cohen, Srivandana Akshintala, Eli Kane, et al.
Cancer Chemotherapy and Pharmacology|October 22, 2015
Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumorsElizabeth Fox, Brigitte C Widemann, Devang Pastakia, et al.
Neuro-Oncology Advances|December 31, 2025
Malignant peripheral nerve sheath tumors in neurofibromatosis type 1 arise from distinct nodular lesions: A retrospective imaging analysisJohannes Salamon, Brigitte C Widemann, Andrea M Gross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Phase I study of O6-benzylguanine and temozolomide administered daily for 5 days to pediatric patients with solid tumorsKatherine E Warren, Alberta A Aikin, Madeleine Libucha, et al.
Investigational New Drugs|December 15, 2015
Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primatesNirali N Shah, Diane E Cole, Cynthia M Lester-McCully, et al.
Ophthalmology|November 8, 2016
Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for CareRobert A Avery, James A Katowitz, Michael J Fisher, et al.
The Journal of Pediatrics|May 27, 2023
Retrospective Cohort Analysis of the Impact of Puberty on Plexiform Neurofibroma Growth in Patients with Neurofibromatosis Type 1Chelsea Kotch, Eva Dombi, Amish C Shah, et al.
Operative Neurosurgery (Hagerstown, Md.)|January 10, 2022
Robotic Nerve Sheath Tumor Resection With Intraoperative Neuromonitoring: Case Series and Systematic ReviewBrian P Curry, Reinier Alvarez, Brigitte C Widemann, et al.
Pediatric Blood & Cancer|August 1, 2012
A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumorsMeredith K Chuk, Alberta Aikin, Trish Whitcomb, et al.
Orphanet Journal of Rare Diseases|October 6, 2012
Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1Rosa Nguyen, Eva Dombi, Brigitte C Widemann, et al.
Pageof 21